Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension [Phase 2]
Phase 2 trial evaluating safety, efficacy, and pharmacokinetics of telmisartan (MICARDIS) in children and adolescents with hypertension has …
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5 [Phase 3]
Phase 3 trial comparing telmisartan/hydrochlorothiazide 80/25 vs 80/12.5 in hypertension not responding to the lower-dose combination.
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg [Phase 3]
Phase 3 trial investigating a switch from telmisartan 80 mg plus hydrochlorothiazide to telmisartan 80 mg alone in patients who failed telmi…
-
CLINICAL_TRIALS trial_result · 2017-12-28Clinical Trial Update: Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension [Phase 3]
Phase 3 factorial trial assessing Telmisartan and Ramipril for hypertension; study completed.
-
FDA approval · 2017-12-19FDA Approved: AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic fixed-dose combination tablet containing amlodipine, valsartan, and hydrochlorothiazide for hypertension. The approva…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-12-19FDA Approved: NIFEDIPINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for a generic nifedipine product by Zydus Lifesciences Limited. The approval covers nifedipine for the…
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: VISN Collaborative for Improving Hypertension Management With ATHENA-HTN [NA]
This ClinicalTrials.gov update notes the completion of the VISN Collaborative for Improving Hypertension Management using ATHENA-HTN and tha…
-
FDA approval · 2017-12-13FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride filed by Hospira, Inc., signaling an additional approval related to the …
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042) [Phase 2]
Phase 2 study of ertugliflozin in adults with type 2 diabetes and hypertension completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Metabonomics to Investigate Effects of Healthy Diets on Blood Pressure: the OmniHeart Study [NA]
The OmniHeart dietary study examining effects of healthy diets on blood pressure has completed.
-
CLINICAL_TRIALS research · 2017-12-11Clinical Trial Update: Understanding Health Care Information for African Americans With High Blood Pressure [NA]
The Johns Hopkins University–sponsored trial evaluating health care information for African Americans with hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: DASH-Sodium Trial in Adolescents [NA]
The DASH-Sodium trial in adolescents has been terminated.
-
FDA approval · 2017-12-08FDA Approved: SODIUM NITROPRUSSIDE — Original Application (Micro Labs Limited)
FDA approved Micro Labs Limited's original ANDA for a generic sodium nitroprusside injection. Sodium nitroprusside is a vasodilator used to …
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Randomized Trial to Evaluate the Effectiveness of Nurse Case Management [NA]
A Johns Hopkins–sponsored randomized trial evaluated the effectiveness of nurse case management for patients with Type 2 diabetes and gestat…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: A Feasibility Study of the Impact on Blood Pressure Control of Supplementing Community Pharmacist Services With Structured Information on Blood Pressure and Its Treatment [NA]
This completed feasibility trial evaluated whether supplementing community pharmacist services with structured information on blood pressure…
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: Systolic Blood Pressure Intervention Trial [NA]
A completed clinical trial update for the Systolic Blood Pressure Intervention Trial (SPRINT) sponsored by NHLBI in hypertension, with resul…
-
FDA approval · 2017-11-30FDA Approved: BYSTOLIC — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for BYSTOLIC (nebivolol hydrochloride) submitted by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Emergency Department Home Blood Pressure Monitoring and BpTRU Study
This update reports the completed results of a clinical trial evaluating emergency department home blood pressure monitoring and the BpTRU d…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Central Blood Pressure
This clinical trial update reports a completed study evaluating central blood pressure in people with hypertension.
-
CLINICAL_TRIALS trial_result · 2017-11-27Clinical Trial Update: WBPS A Prospective, Method Comparison, Proof of Concept Study [NA]
A completed prospective, method-comparison, proof-of-concept study related to blood pressure measurement conducted by CSEM.
-
FDA approval · 2017-11-27FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Original Application (Zydus Lifesciences Limited)
FDA approves Zydus Lifesciences' generic fixed-dose combination of candesartan cilexetil and hydrochlorothiazide for the treatment of hypert…
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart [Phase 4]
Phase 4 study assessing Nebivolol's impact on blood flow in the hearts of adults with hypertension and abnormal filling of the heart has com…
-
CLINICAL_TRIALS research · 2017-11-21Clinical Trial Update: Matão Controlling Hypertension (MatCH Study): Rationale and Design [EARLY_Phase 1]
This document outlines the rationale and design of the Matão Controlling Hypertension (MatCH) study, an early-phase 1 trial investigating hy…
-
FDA approval · 2017-11-20FDA Approved: CLONIDINE HYDROCHLORIDE — Original Application (Xiamen LP Pharmaceutical Co., Ltd.)
FDA approves the original application for clonidine hydrochloride from Xiamen LP Pharmaceutical Co., Ltd., granting a generic version of the…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Is a Smartphone Application Effective as an Oral Medication Adherence Aid [EARLY_Phase 1]
An early-phase 1 trial evaluating a smartphone application to improve oral medication adherence was terminated; the study involved hypertens…